双锥度模块化股骨柄锥度腐蚀患者中的无症状假瘤:MARS-MRI与金属离子研究
该回顾性横断面研究纳入97例接受双锥度模块化股骨柄全髋关节置换术的患者,其中83例分为有症状组和无症状组,行MARS-MRI、血清金属离子检测及UCLA功能评分。无症状患者中假瘤患病率为15%,整体队列为36%;有假瘤者血清钴水平及钴/铬比值显著高于无假瘤者,但有症状与无症状假瘤患者间无显著差异。
要点
- 无症状患者中MARS-MRI检出假瘤的患病率为15%,整体队列为36%。
- 有假瘤者血清钴中位数8.0 μg/L vs 无假瘤者2.0 μg/L(p=0.004)。
- 有症状与无症状假瘤患者间血清钴及钴/铬比值无显著差异。
核心结论
- 无症状患者中MARS-MRI检出锥度腐蚀相关假瘤的患病率表明,无症状不能排除不良局部组织反应的存在。
- 血清钴水平及钴/铬比值升高与有症状和无症状患者中假瘤的存在相关。
- 对于金属离子水平升高的患者,有指征行MARS-MRI等横断面影像检查。
- 需要纵向研究以确定无症状的锥度腐蚀相关假瘤患者是否会随时间出现症状。
研究设计与样本
- 回顾性横断面研究,纳入97例连续接受双锥度模块化股骨柄全髋关节置换术的患者,其中83例分为有症状组和无症状组,评估MARS-MRI、血清金属离子水平及UCLA功能髋评分。
- 证据等级:治疗性IV级。
主要发现
- 无症状患者中MARS-MRI确定的假瘤患病率为15%,整体队列为36%。
- 有假瘤者血清钴中位数8.0 μg/L vs 无假瘤者2.0 μg/L(p=0.004),钴/铬比值中位数10.3 vs 2.4(p=0.012)。
- 有症状假瘤患者与无症状假瘤患者间血清钴水平(7.6 vs 6.2 μg/L,p=0.37)及钴/铬比值(8.3 vs 10.6,p=0.46)无显著差异。
- 无症状假瘤患者UCLA评分与无假瘤患者相似(6.7 vs 6.6)。
临床怎么用
- 对于金属离子水平升高的患者,有指征行MARS-MRI等横断面影像检查。
- 无症状不能排除锥度腐蚀相关假瘤的存在。
- 需要纵向研究以确定无症状假瘤患者是否随时间出现症状。
局限性
- 需要纵向研究以确定无症状的锥度腐蚀相关假瘤患者是否会随时间出现症状。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Modularity in total hip arthroplasty facilitates intraoperative restoration of patient anatomy. Although dual-taper modular total hip arthroplasty offers potential advantages for optimizing the hip center of rotation, it has been associated with modular taper corrosion. This corrosion has led to adverse local tissue reactions (pseudotumors) at the neck-stem junction and elevated metal-ion levels. However, the occurrence of taper-corrosion-related pseudotumors in patients who remain asymptomatic following total hip arthroplasty with a dual-taper modular femoral stem remains largely unknown. The aims of this study were (1) to determine the prevalence of asymptomatic pseudotumors by utilizing metal artifact reduction sequence magnetic resonance imaging (MARS-MRI) and (2) compare serum metal-ion levels between symptomatic and asymptomatic patients with a dual-taper modular stem total hip replacement. METHODS: We performed a retrospective cross-sectional study of 97 consecutive patients who had been treated with a dual-taper modular femoral stem total hip arthroplasty. Eighty-three patients were stratified into symptomatic and asymptomatic groups and evaluated with MARS-MRI, measurement of serum metal-ion levels, and the University of California at Los Angeles (UCLA) functional hip score. RESULTS: The prevalence of pseudotumors as determined with MARS-MRI was 15% in our asymptomatic patients and 36% in the overall cohort. The median serum cobalt level and cobalt/chromium ratio were significantly higher in patients with a pseudotumor than in those without a pseudotumor (8.0 versus 2.0 μg/L [p = 0.004] and 10.3 versus 2.4 μg/L [p = 0.012], respectively). However, there was no significant difference in the serum cobalt level or cobalt/chromium ratio between symptomatic patients with a pseudotumor and asymptomatic patients with a pseudotumor (7.6 versus 6.2 μg/L [p = 0.37] and 8.3 versus 10.6 μg/L [p = 0.46], respectively). The UCLA scores of asymptomatic patients with a pseudotumor were similar to those of patients without a pseudotumor (6.7 versus 6.6). CONCLUSIONS: The prevalence of asymptomatic taper-corrosion-related pseudotumors on MARS-MRI in this study demonstrated that the absence of symptoms does not exclude the presence of adverse local tissue reactions. Elevated cobalt levels and cobalt/chromium ratios were associated with the presence of pseudotumors in asymptomatic and symptomatic patients. Cross-sectional imaging such as MARS-MRI is indicated for patients with elevated metal-ion levels. A longitudinal study is required to determine whether asymptomatic patients with taper-corrosion-related pseudotumors will develop symptoms with time. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
引用
- Kwon YM, Khormaee S, Liow MH, et al. Asymptomatic Pseudotumors in Patients with Taper Corrosion of a Dual-Taper Modular Femoral Stem: MARS-MRI and Metal Ion Study. J Bone Joint Surg Am. 2016. PMID: 27869625
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。